In the last two decades, many efforts have been directed toward developing new potential diagnostic tools for improving thyroid cancer diagnosis preoperatively, and galectin-3 is probably one of the most extensively-studied marker so far. This evidence concerns the gene LGALS3 and thyroid gland carcinoma.